Clinical Trial Update: Retrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis Trial [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating retrobulbar methylprednisolone as an adjunctive treatment for optic neuritis. Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Neuritis

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Optic Neuritis, Treatment | Phase 2, Phase 3 | Status: UNKNOWN